355 articles
Michael Pfreundschuh
Michael Pfreundschuh (1949–2018) was a German hematologist and oncologist, professor at Saarland University in Homburg, who developed the SEREX method for identifying human tumor antigens.
Michael Untch
Michael Untch, born 1957 in Transylvania, is a German gynecologic oncologist who led the breast cancer center at Helios Klinikum Berlin-Buch and shaped treatment for HER2-positive breast cancer.
Michael V. Seiden
Michael V. Seiden is an American oncologist known for ovarian cancer research and as president and CEO of Fox Chase Cancer Center from 2007 to 2013.
Michael Wang (hematologist-oncologist)
Michael (Luhua) Wang is a Chinese-American hematologist-oncologist at MD Anderson Cancer Center who directs its Mantle Cell Lymphoma Program of Excellence and has published over 150 papers.
Michiel S. van der Heijden
Michiel S. van der Heijden is a Dutch medical oncologist and research group leader at the Netherlands Cancer Institute in Amsterdam, known for immunotherapy trials in bladder cancer.
Miguel Martín (oncologist)
Miguel Martín Jiménez is a Spanish medical oncologist specializing in breast cancer, head of medical oncology at the Gregorio Marañón hospital in Madrid since 2009.
Min Chiu Li
Min Chiu Li (李敏求; 1919–1980) was an oncologist who produced the first drug cure of a solid cancer, metastatic choriocarcinoma, at the National Cancer Institute in 1956.
Mortimer B. Lipsett
Mortimer B. Lipsett (1921–1985) was an American endocrinologist and physician-scientist at the NIH who helped make choriocarcinoma the first cancer cured by chemotherapy alone, and held three NIH directorships.
Mrinal M. Gounder
Mrinal M. Gounder is an American medical oncologist at Memorial Sloan Kettering Cancer Center specializing in sarcomas and desmoid tumors, and led the nirogacestat trials.
Myriam Chalabi
Myriam Chalabi is a Dutch medical oncologist and clinical group leader of gastrointestinal oncology at the Netherlands Cancer Institute in Amsterdam, known for the NICHE immunotherapy trials.
Nadia Harbeck
Nadia Harbeck is a German breast oncologist who directs the Breast Center of the LMU women's hospital in Munich and led the IMpassion031 trial of atezolizumab in triple-negative breast cancer.
Nagahiro Saijo
Nagahiro Saijo (西條長宏) is a Japanese medical oncologist known for lung cancer drug trials, founding the Japan Society of Medical Oncology, and leading the JCOG 9511 trial.
Nancy E. Kemeny
Nancy E. Kemeny is an American medical oncologist at Memorial Sloan Kettering known for developing hepatic arterial infusion chemotherapy for colorectal cancer that has spread to the liver.
Nasser H. Hanna
Nasser H. Hanna is an American medical oncologist at the Indiana University School of Medicine in Indianapolis, known for lung cancer clinical research and founding End Lung Cancer Now.
Nathanael S. Gray
Nathanael S. Gray is a chemical and systems biologist and the Krishnan-Shah Family Professor at Stanford University whose laboratory's cancer drug discovery informed ceritinib, osimertinib, and asciminib.
Nicholas J. Vogelzang
Nicholas J. Vogelzang was an American medical oncologist specializing in genitourinary cancers and mesothelioma who led trials producing approvals of pemetrexed, abiraterone, and atezolizumab, and died in 2022.
Nicholas Lydon
Nicholas Lydon is a British biochemist who led the Ciba-Geigy tyrosine-kinase program that discovered imatinib (Gleevec), the first drug designed to inhibit a specific protein kinase.
Nima Sharifi
Nima Sharifi is a prostate cancer medical oncologist and physician-scientist who identified the HSD3B1 mutation driving castration-resistant prostate cancer, leading the Desai Sethi Urology Institute since 2023.
Oliver Sartor
Oliver Sartor, also known as A. Oliver Sartor, is an American medical oncologist known for leading phase 3 trials of radium-223 and lutetium-177 prostate cancer therapies.
Olivia Pagani
Olivia Pagani is a Swiss-Italian medical oncologist specializing in breast cancer, best known for leading the TEXT and SOFT trials of ovarian suppression and the POSITIVE trial allowing pregnancy after breast cancer.
Parkash S. Gill
Parkash S. Gill is an American oncologist and physician-scientist at USC's Keck School of Medicine, known for Kaposi's sarcoma research and developing three FDA-approved cancer drugs.
Patricia LoRusso
Patricia M. LoRusso is an American medical oncologist who leads early-phase clinical trials of experimental cancer drugs at Yale, after 26 years building phase I trials at Wayne State's Karmanos Cancer Institute.
Patrick J. Loehrer
Patrick J. Loehrer is an American medical oncologist at the Indiana University School of Medicine whose trials helped define modern cisplatin-based treatment of testicular cancer.
Patrick Johnston (medical oncologist)
Patrick Gerard Johnston, known as Paddy, was a Northern Irish medical oncologist who researched chemotherapy drug resistance in gastrointestinal cancer and led Queen's University Belfast from 2014 until his death in 2017.
Patrick Schöffski
Patrick Schöffski is a German medical oncologist and full professor at KU Leuven who heads medical oncology at University Hospitals Leuven and sarcoma drug trials.
Paul A. Bunn
Paul A. Bunn is an American medical oncologist at the University of Colorado Cancer Center, known for lung cancer research and for leading ASCO and the IASLC.
Paul Calabresi
Paul Calabresi (1930–2003) was an Italian-born American physician-scientist and pioneer of medical oncology who served as Brown University's first Chairman of Medicine and advised national cancer policy.
Paul G. Richardson
Paul G. Richardson is an American hematologist-oncologist at Dana-Farber Cancer Institute and Harvard Medical School whose clinical trials established standard multiple myeloma drugs, including bortezomib and lenalidomide.
Paul J. Hesketh
Paul J. Hesketh is an American medical oncologist who directs the Lahey Cancer Institute in Massachusetts and shaped the prevention of chemotherapy-induced nausea and vomiting.
Paul P. Carbone
Paul P. Carbone was an American medical oncologist who helped develop MOPP and CMF chemotherapy, led ECOG, shared the 1972 Lasker Award, and directed the UW Comprehensive Cancer Center.